Overall, these data show that PEDF expression is significantly reduced in endocrine-resistant breast cancer cells compared with endocrine-sensitive cells and that its expression is differentially regulated by estrogen and anti-estrogen in hormone-dependent breast cancer cells. Here, SERPINF1 is linked to breast carcinoma.